Telix Pharmaceuticals Net Worth
Telix Pharmaceuticals Net Worth Breakdown | TLX |
Telix Pharmaceuticals Net Worth Analysis
Telix Pharmaceuticals' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Telix Pharmaceuticals' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Telix Pharmaceuticals' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Telix Pharmaceuticals' net worth analysis. One common approach is to calculate Telix Pharmaceuticals' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Telix Pharmaceuticals' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Telix Pharmaceuticals' net worth. This approach calculates the present value of Telix Pharmaceuticals' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Telix Pharmaceuticals' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Telix Pharmaceuticals' net worth. This involves comparing Telix Pharmaceuticals' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Telix Pharmaceuticals' net worth relative to its peers.
Enterprise Value |
|
To determine if Telix Pharmaceuticals is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Telix Pharmaceuticals' net worth research are outlined below:
| Telix Pharmaceuticals generated a negative expected return over the last 90 days | |
| Latest headline from finance.yahoo.com: 3 Stocks That May Be Undervalued By Up To 43.6 percent Based On Intrinsic Estimates |
Telix Pharmaceuticals Quarterly Good Will |
|
Follow Telix Pharmaceuticals' market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 4.93 B.Market Cap |
|
Project Telix Pharmaceuticals' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.02 | 0.02 | |
| Return On Capital Employed | 0.07 | 0.07 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.03 | 0.04 |
When accessing Telix Pharmaceuticals' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Telix Pharmaceuticals' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Telix Pharmaceuticals' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Telix Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Telix Pharmaceuticals Limited. Check Telix Pharmaceuticals' Beneish M Score to see the likelihood of Telix Pharmaceuticals' management manipulating its earnings.
Evaluate Telix Pharmaceuticals' management efficiency
Telix Pharmaceuticals has Return on Asset of 0.0797 % which means that on every $100 spent on assets, it made $0.0797 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2049 %, implying that it generated $0.2049 on every 100 dollars invested. Telix Pharmaceuticals' management efficiency ratios could be used to measure how well Telix Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.02 in 2024. Return On Capital Employed is likely to rise to 0.07 in 2024. At this time, Telix Pharmaceuticals' Other Current Assets are fairly stable compared to the past year. Return On Tangible Assets is likely to rise to 0.02 in 2024, whereas Total Assets are likely to drop slightly above 253.4 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.15) | (0.18) | |
| Tangible Book Value Per Share | (0.25) | (0.26) | |
| Enterprise Value Over EBITDA | (4.45) | (4.67) | |
| Price Book Value Ratio | (4.22) | (4.43) | |
| Enterprise Value Multiple | (4.45) | (4.67) | |
| Price Fair Value | (4.22) | (4.43) | |
| Enterprise Value | 8.1 M | 7.7 M |
The decision-making processes within Telix Pharmaceuticals are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Enterprise Value Revenue 11.5108 | Revenue 645.7 M | Quarterly Revenue Growth 0.581 | Revenue Per Share 1.991 | Return On Equity 0.2049 |
Telix Pharmaceuticals Earnings per Share Projection vs Actual
Telix Pharmaceuticals Corporate Management
| Richard MBA | Chief Therapeutics | Profile | |
| BSc BSc | Chief Scientist | Profile | |
| Lena LLB | Group Counsel | Profile | |
| Andreas MD | Chief Advisor | Profile | |
| Darren Patti | Group Officer | Profile | |
| Craig Ulrick | Chief Officer | Profile |
Additional Tools for Telix Stock Analysis
When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.